BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT04128696-completion@plaintrial.com
DTSTAMP:20261028T182555Z
DTSTART;VALUE=DATE:20230620
SUMMARY:Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 
 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous
  Cell Carcinoma — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT04128696
URL:https://plaintrial.com/trial/NCT04128696
END:VEVENT
END:VCALENDAR